Abstract
This article aims to review research in nonhuman primates demonstrating that norepinephrine can enhance the cognitive functioning of the prefrontal cortex through actions at alpha 2 A-adrenergic receptors postjunctional to noradrenergic terminals. As prefrontal cortex cognitive deficits are prominent in several psychiatric disorders, including attention-deficit hyperactivity disorder, these basic findings may have relevance for the development of novel pharmacotherapies.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Adrenergic alpha-Agonists / therapeutic use
-
Animals
-
Attention Deficit Disorder with Hyperactivity / physiopathology*
-
Clonidine / pharmacology
-
Clonidine / therapeutic use
-
Cognition Disorders / drug therapy
-
Guanfacine / pharmacology
-
Guanfacine / therapeutic use
-
Haplorhini
-
Humans
-
Locus Coeruleus / drug effects
-
Locus Coeruleus / physiology
-
Models, Neurological
-
Neural Pathways / drug effects
-
Neural Pathways / physiology
-
Norepinephrine / pharmacology*
-
Norepinephrine / physiology
-
Prefrontal Cortex / drug effects
-
Prefrontal Cortex / physiology*
-
Receptors, Adrenergic, alpha-2 / drug effects
-
Receptors, Adrenergic, alpha-2 / physiology*
Substances
-
Adrenergic alpha-Agonists
-
Receptors, Adrenergic, alpha-2
-
Guanfacine
-
Clonidine
-
Norepinephrine